mri of liver with gd-enhancement studies :
        
  techniques: 
  the patient is lying on the mri gantry in supine position
  pul sequence --> pre-enhanced : t1w (in-phase, out-phase), t2w, 
                                  t2fs, heavy t2  
                   post-enhanced : t1w triphase
    
  imaging  findings:
  mild lobulated contour of liver contour
  splenomegaly
  a 2.8cm mass in s5 liver surface with fatty content shows hypointense 
  on t1 and isointense on t2w fat suppression image
  gd-dtpa dynamic enhanced study shows early enhancement and early 
  washout of the mass
  patent mpv and branches, no evidence of thrombosis
  a 2.9cm mass with internal septation in superior anterior aspect 
  of spleen, hypointense on t1w, hyperintense on t2w, and mild 
  enhancement of the internal septi in enhanced study
  no definite space occupying lesion in the pancreas
  no definite biliary dilatation. not well distension of gb
  no definite obstructive uropathy  .
  no definite enlargement of retroperitoneal lns  .
  no abnormal fluid collection in the abdomen  .
    
  impression:
  1.liver cirrhosis with splenomegaly
  2.s5 mass(2.8cm), increase size compare with prior ct studies, 
  hcc with fatty metamorphosis is suspected.
  3.splenic mass (2.9cm) with internal septi and poor enhancement, 
  suspect splenic lymphangioma.
  
  ¡´tnm for hepatocellua carcinoma (ajcc 7th edition)
  1.tumor location: s5
  2.tumor size: 2.8cm
  3.pathology: ¡´not available ¡³available (pathology type:¡¼)
  
  -------------------primary tumor(t)-------------------
   tx    ¡³primary tumor cannot be assessed ¡¼
   t0    ¡³no primary tumor ¡¼
  stage i
   t1    ¡´solitary tumor without vascular invasion ¡¼
  stage ii
   t2    ¡³solitary tumor with vascular invasion
         ¡³multiple tumors none more than 5 cm
  
  stage iii
   a t3a ¡³multiple tumors more than 5 cm ¡¼
   b t3b ¡³single tumor or multiple tumors of any size
         involving a major branch of the portal vein or
         hepatic vein ¡¼
   c t4  ¡³tumor(s) with direct invasion of adjacent
         organs other than the gallbladder or with
         perforation of visceral peritoneum. ¡¼
  
  -------------------regional lymph nodes(n)-----------------
   nx    ¡³regional lymph nodes cannot be assessed ¡¼
   n0    ¡´no regional lymph nodes ¡¼
  stage iva
   n1    ¡³regional lymph node metastasis ¡¼
  
  -------------------distant metastasis(m)-------------------
   m0    ¡³no distant metasmri of liver  without & with contrast enhancement and with mra for liver
 transplant
pulse sequences:
axl t1wi ,  t2wi,  long t2w1 & dwi, 8mm in thickness & 2 mm gap for whole liver;
   axl t1wic+ 15 sec after iv infusion of gd-dtpa 0.2ml/kg,  8mm in  thickness 
and 2 mm gap for whole liver, followed by 30 sec intervals  for the 2nd and 3rd 
t1wi c+.  mra with reconstructive vascular images are also performed according 
to the pathway of the hepatic artery, portal vein and inferior vena cava.
 
findings:
lobulated contour of liver compatible with liver cirrhosis  .
a 4.2 cm tumor over segment 8 of the liver  
the signal intensity of the tumor is low on t1w and high on t2w. the enhancement
 pattern is early enhanced and with early washed out. 
no definite enlargement of retroperitoneal lns  .
splenomegaly  
no ascites in the abdomen
normal biliary tree
patency of the hepatic artery  
patency of the ivc and pv. 
the size of the mpv is 1.4cm
prominent of the coronary vein 1.3cm with gastric and esophageal varices 
recanalization of the umbilical vein with size of  0.66cm
 
 
imp: 
liver cirrhosis for liver transplant
a 4.2 cm hcc over s8 liver


¡´imaging report form for hepatocellua carcinoma (ajcc 8th edition)
1.tumor number/location: 
number: ¡´1 ¡³2 ¡³3 multiple:
location: s8
2.tumor size: 
    ¡³measurable: 4.2 cm (the largest tumor)
    ¡³non-measurable
3.tumor characteristics and associated liver features
    ¡³vascular invasion 
    ¡³extrahepatic spread 
    ¡³ascites 
    ¡³portal vein thrombosis, location 
    ¡³portosystemic collateral vessel
    ¡´typical enhancement pattern (hypervascular enhancement and early wash-out)
3.pathology: ¡´not available ¡³available (pathology type:¡¼)

-------------------primary tumor(t)--------------------------
 tx  ¡³ primary tumor cannot be assessed 
 t0  ¡³ no primary tumor 
stage i
t1   ¡³ solitary tumor ¡Ø2 cm, or > 2cm without vascular invasion
t1a  solitary tumor ¡Ø2 cm
t1b  ¡´solitary tumor > 2cm without vascular invasion
stage ii
t2   ¡³ solitary tumor >2cm with vascular invasion, or multiple tumors,none >5
cm 
stage iii
t3   ¡³multiple tumors more than 5 cm 
t4   ¡³tsingle tumor or multiple tumors of any size involving a major
branch of the portal vein or hepatic vein, or tumor(s) with direct
invasion of adjacent organs other than the gallbladder or with
perforation of visceral peritoneum 
-------------------regional lymph nodes(n)-----------------
nx   ¡³regional lymph nodes cannot be assessed 
n0   ¡´no regional lymph nodes
stage iva
n1   ¡³regional lymph node metastasis 
     ¡³periceliac, ¡³hilar( common bile duct, hepatic artery, portal vein and 
cystic duct) ¡³peripancreatic ¡³paraaortic ¡³portocaval ¡³retrocaval
¡³others  __ 
-------------------distant metastasis(m)----------------------
stage ivb
m1  ¡³distant metastasis
¡³	invasion of gallbladder
¡³	cardiophrenic, mesenteric, retrocrural ln
imaging stage   t1b n0( in this study)tasis¡¼
  stage ivb
   m1    ¡³distant metastasis¡¼
  
  imaging stage   t1 n0 mx
                stage i